Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

P&G agrees $4.2bn buy of Merck KGaA’ s consumer health unit. ... The game of pass-the-parcel for pharma’s unwanted divisions continues apace, with Proctor &Gamble agreeing to take control of Merck KGaA’s consumer health business.

Pfizer’s plans for Inlyta go awry with failed adjuvant trial

Pfizer’s plans for Inlyta go awry with failed adjuvant trial The failure of ATLAS means Pfizer now has a lot more riding on its JAVELIN trial of Inlyta in combination with Merck KGaA-partnered PD-L1 inhibitor Bavencio (avelumab) in

Sanofi’s PD-1 inhibitor starts EU review for skin cancer

Sanofi’s PD-1 inhibitor starts EU review for skin cancer intended - to help it break into one of the most hotly-contested pharma markets, currently led by Bristol-Myers Squibb and Merck &Co/MSD. ... In addition to chasing companies in the category with already-marketed drugs - which also include Roche,

Merck KGaA inks deal for Medisafe adherence app

Merck KGaA inks deal for Medisafe adherence app Merck KGaA inks deal for Medisafe adherence app. The digital programme will be initially rolled out in Brazil, Russia and Mexico. ... Merck KGaA has signed a wide-ranging deal with US-Israeli company Medisafe to develop customised versions of its

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics